Previous Article | Next Article ![]()
Applied and Environmental Microbiology, July 2001, p. 2982-2992, Vol. 67, No. 7
School of Biological Sciences, University of
Nebraska, Lincoln, Nebraska 68588-06661;
Biological Sciences, College of St. Benedict's and St. John's
University, Collegeville, Minnesota 563212; and
Department of Chemistry, University of Nebraska, Lincoln,
Nebraska 68588-03043
Received 31 October 2000/Accepted 26 February 2001
The inoculum size effect in the dimorphic fungus Candida
albicans results from production of an extracellular
quorum-sensing molecule (QSM). This molecule prevents mycelial
development in both a growth morphology assay and a differentiation
assay using three chemically distinct triggers for germ tube formation
(GTF): L-proline, N-acetylglucosamine, and
serum (either pig or fetal bovine). In all cases, the presence of QSM
prevents the yeast-to-mycelium conversion, resulting in actively
budding yeasts without influencing cellular growth rates. QSM exhibits
general cross-reactivity within C. albicans in that
supernatants from strain A72 are active on five other strains of
C. albicans and vice versa. The QSM excreted by C. albicans is farnesol (C15H26O; molecular
weight, 222.37). QSM is extracellular, and is produced continuously
during growth and over a temperature range from 23 to 43°C, in
amounts roughly proportional to the CFU/milliliter. Production is not
dependent on the type of carbon source nor nitrogen source or on the
chemical nature of the growth medium. Both commercial mixed isomer and (E,E)-farnesol exhibited QSM activity (the ability to
prevent GTF) at a level sufficient to account for all the QSM activity present in C. albicans supernatants, i.e., 50% GTF at ca.
30 to 35 µM. Nerolidol was ca. two times less active than farnesol. Neither geraniol (C10), geranylgeraniol (C20),
nor farnesyl pyrophosphate had any QSM activity.
The dimorphic fungus Candida
albicans is one of the most important fungi in medicine
(26). It is a member of the normal flora residing in the
intestinal tract of humans and other animals and is thought to be
acquired during passage through the birth canal (26).
C. albicans is also the model system for studying the basic
biology of dimorphic fungi. Because of its medical importance, molecular tools are available with C. albicans that are
unavailable for other dimorphic fungi (3). One unresolved
problem in fungal biology is the dependence of cell morphology on
initial cell density. For fungi exhibiting yeast-mycelium dimorphism,
this phenomenon has been termed the inoculum size effect
(19). Under otherwise identical conditions, budding yeasts
are produced following inoculation at In this study we isolate and characterize the extracellular
quorum-sensing molecule (QSM) which is responsible for the inoculum size effect in C. albicans. Quorum sensing is a well-known
phenomenon in prokaryotes, but it has as yet only been hinted at in
eukaryotes (18). Furthermore, since quorum sensing uses
extracellular signal molecules, it is poised to mediate interactions of
the producing fungus with its chemical and physical environment as well
as with other bacteria and fungi. This study is the first to identify an extracellular molecule (farnesol) which mediates a eukaryotic quorum-sensing system.
Organisms.
C. albicans strains A-72 and SG10261
were obtained from Patrick Sullivan, University of Otago, Dunedin,
while strain MEN was from Richard Cannon, University of Otago. Strain
SG5314 was from Burk Braun, University of California at San Francisco,
and strains LGH 1095 and SG3314 were from Kevin Hazen, Virginia
Polytechnic Institute and State University. Homoserine lactone (HSL)
indicator strains were obtained from Sue Katz, Arizona College of
Osteopathic Medicine, Glendale. (i) Chromobacterium
violaceum CV026 was maintained on Luria-Bertani (LB) agar plus
kanamycin (25 µg/ml). It detects four to eight carbon N-acyl HSLs.
(ii) Agrobacterium tumefaciens A136 (originally from Clay
Fuqua) was maintained on LB agar plus tetracycline (4.5 µg/ml) and
spectinomycin (50 µg/ml). It detects most C4 to
C12 HSLs, regardless of whether their side chains are 3-oxo, 3-hydroxy, or 3-unsubstituted (5, 29). (iii)
Escherichia coli strains MG4/pKDT17, DH5 Growth media and chemicals.
GPP is the defined
glucose-phosphate-proline growth-medium described by Kulkarni and
Nickerson (19). The modified glucose-salts-biotin (GSB)
growth medium contained (per liter of distilled water): 1 g of
(NH4)2SO4, 2 g of
KH2PO4, 50 mg of MgSO4 · 7H2O, 50 mg of CaCl2 · 2H2O,
and 1 g of peptone. After autoclaving, 30 ml of a 50% (wt/vol) glucose
stock and 0.4 ml of the GPP/GPR vitamin stock (19) were
added aseptically. The final pH was ca. 5.6. The modified GSB was used
for preparing C. albicans cell stocks. Cells were harvested
after 30 h of growth, washed twice in 50 mM
K2HPO4 buffer (pH 6.5), and stored at 4°C in
the same buffer at a cell density of ca. 2 × 109 cells/ml.
Supernatants containing QSM activity were prepared following 24 h
of growth in GPP at 28°C, starting with an initial cell density of
107 cells/ml. For QSM preparation, GPP was always prepared
with Kandiyohi distilled water (Kandiyohi Bottled Water Co., Willmar,
Minn.). This precaution was taken because several types of distilled
water, including the building distilled water for the Beadle Center at the University of Nebraska at Lincoln, permitted ample growth of
C. albicans, but the resulting cell-free supernatants did
not contain QSM activity. Currently, five of eight distilled waters locally available in Lincoln and central Minnesota permit QSM accumulation. For the experiments to determine the influence of carbon
source on QSM production, the glucose in GPP was replaced successively
by lactose, sucrose, galactose, fructose, starch, and glycerol. For the
experiments to determine the influence of nitrogen source on QSM
production, the proline in GPP was replaced successively by
L-serine, L-arginine, L-alanine,
L-histidine, L-threonine,
L-methionine, and L-phenylalanine. The pH
values for all of the resulting spent media were very similar (pH 6.1 to 6.4). The sample of mixed isomer farnesol was purchased from Acros
Organics (Pittsburgh, Pa.) while (E,E)-farnesol and farnesyl pyrophosphate were purchased from Sigma (St. Louis, Mo.).
(E,E)-Farnesol is also called trans-trans farnesol.
QSM bioassay.
Two complementary bioassays were used, both
assessing the percent germ tube formation (GTF) at 37°C but differing
in whether or not the cells are provided with a complete growth medium
during the bioassay. The first, an N-acetylglucosamine
(GlcNAc)-triggered differentiation assay, included 0.56 ml of 0.1 M
imidazole buffer (pH 6.5), 0.15 ml of 0.1 M MgSO4, 0.13 ml
of 0.1 M GlcNAc, and 4.16 ml of either Kandiyohi distilled water or
filter-sterilized supernatant.
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.7.2982-2992.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Quorum Sensing in the Dimorphic Fungus
Candida albicans Is Mediated by Farnesol


![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
106 cells/ml,
whereas germ tubes and mycelia are produced with inocula of
<106 cells/ml. We believe the inoculum size effect is a
general phenomenon for all dimorphic fungi. This effect has been
especially well documented for C. albicans. Cell density is
listed by Odds (26) as 1 of 11 general factors favoring
the filamentous form.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/pECP 615, and
DH5
/pQF300I were all maintained on LB agar plus ampicillin (100 µg/ml). They detect C10 to C14 3-oxo and
3-unsubstituted HSLs, PAI-2, and the Vibrio fischeri
autoinducer 3-oxo C6 HSL, respectively. QSM from C. albicans was concentrated by extraction into ethyl acetate
(6) and then tested for its reactivity toward five
bacteria which had been designed as indicator strains for the presence
of various HSLs. C. violaceum CV026 produces a purple
pigment in response to the appropriate HSL, while the other strains
produce
-galactosidase. The CV026 assay was done on LB agar, the
three E. coli assays were done on LB agar with ampicillin
(100 µg/ml) and
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal;
40 µg/ml), and the A136 assay was done on the minimal, defined
AT-glucose agar (33) with X-Gal (40 µg/ml).
Purification of QSM. Five liters GPP was inoculated to a final concentration of 107 cells/ml and incubated at 30°C for 24 h on a New Brunswick Scientific G52 shaker at 125 rpm. After 24 h the cultures were centrifuged at 15,300 × g for 20 min. The supernatant was decanted and filter sterilized by vacuum filtration through Whatman (Maidstone, United Kingdom) 0.45-µm (pore-size) cellulose nitrate filters. The cell-free supernatant was either designated as spent medium for use in a QSM assay or extracted with a one-fifth volume of ethyl acetate. The ethyl acetate was removed under reduced pressure on a rotary evaporator. The residue was suspended in a small volume of 1:4 ethyl acetate-hexane and the soluble portion was subjected to silica flash chromatography with 1:4 ethyl acetate-hexane as the eluant. Individual fractions (1 ml) were examined by thin-layer chromatography (TLC).
TLC. TLC was conducted on silica gel G plates (Al or glass backed) containing a fluorescent indicator (Alltech, Deerfield, Ill.). Reagents used for staining included 1% aqueous KMnO4, an indicator for alkenes, and a mixture of p-anisaldehyde and sulfuric acid in 1:1 methanol-water, which chars to reveal a variety of organic functional groups. The mobile phase used was 1:4 ethyl acetate-hexane.
HPLC. High-performance liquid chromatography (HPLC) analysis employed a Waters (Milford, Mass.) pump model 510 and a Waters Tunable Absorbance Detector model 486. Data were analyzed by using Millennium 2010 Chromatography Manager software version 2.00 from Waters. A 5-µm C18 reversed-phase column (4.6 by 250 mm) was used with the following parameters: 210-nm, 1-ml/min flow rate, and 4:1 methanol-H2O eluant.
GC-MS. Active fractions were resuspended in 100% methanol and analyzed by a Hewlett-Packard 5972 Series II gas chromatography-mass spectroscopy (GC-MS) with a 30-m DB-5 column in both the chemical ionization (methane) and electron ionization (EI) modes. GC used a 1.5-µl sample, injector, and detector temperatures of 250 and 280°C, respectively, and a temperature program of 100°C for 3 min and then 20°C/min until 280°C. MS used a 3-min solvent delay and a scan rate of 1.5 scans/s.
Trimethylsilyl derivatization. Derivatization of the hydroxyl groups of commercial farnesol and QSM was accomplished by the addition of N,O-bis(trimethyl)trifluoroacetamide (BSTFA; Alltech). The samples were suspended in 500 µl of ethyl acetate, from which 150 µl was removed for analysis as "prior to derivatization." To the remaining 350 µl, 100 µl of BSTFA was added. The samples were heated for 15 min at 70°C in a water bath and, after cooling, were submitted directly for GC-MS.
| |
RESULTS |
|---|
|
|
|---|
QSM from C. albicans.
Including spent media from
C. albicans as part of the fresh growth media caused a
gradual shift in the morphology of C. albicans. At 37°C,
with no added culture supernatant, the cells were ca. 90% mycelia.
Incorporation of spent growth medium progressively decreased the
percent mycelia to only 5 to 10% (Fig.
1). This decrease in the percent mycelia
occurred for both a complete growth medium and a GlcNAc-induced
differentiation assay for GTF. In both cases, QSM did not just prevent
GTF but also caused a morphological shift to actively budding yeast
cells.
|
Generality within C. albicans.
QSM activity was
not specific for strain A72; it was general for all strains of C. albicans (Table 1). Supernatant from
strain A72 caused a mycelium-to-yeast conversion in cells from
strains MEN, SG5314, LGH1095, SG3314, and 10261 (Table 1). Similarly, supernatants from strains MEN, SG5314, LGH1095, SG3314, and 10261 caused a mycelium-to-yeast conversion in A72 cells (Table 1). Thus, all
six strains of C. albicans produce QSM activity, and the
QSMs for the six strains are either identical or very similar to one
another.
|
|
Production of QSM by C. albicans.
QSM was produced
by C. albicans cells growing at all temperatures tested from
23 to 43°C (Table 3). From 23 to
37°C, there was a rough correlation between cell number (in
CFU/milliliters) and levels of QSM produced, as indicated by the lower
percent mycelia when those supernatants were tested in a germ tube
bioassay (Table 3). However, on a per-cell basis, significantly more
QSM was produced by cells grown at 40°C than at any other temperature (Table 3).
|
|
Preliminary evidence on the chemical identity of QSM.
For
C. albicans, QSM activity could be extracted into ethyl
acetate and then resuspended in either hexane or 90% methanol (6, 21). Following an activity-directed purification,
activity was associated with a fraction containing a molecular mass of 222 (6, 21). Cho et al. (6) eliminated the
possibilities that QSM was methyl jasmonate or a lactone of jasmonic
acid or homojasmonic acid. Active fractions of QSM are stained by
dilute aqueous KMnO4 on silica TLC, indicating the presence
of carbon-carbon multiple bonds; absorb UV light at 210 to 220 nm but
not at wavelengths of
240 nm; contain a free hydroxyl, as shown by
altered mobility on TLC plates following trimethylsilylation; do not
contain a free carboxylic acid, as shown by unaltered TLC mobility
following reaction with diazomethane; and do not contain an ester
linkage, as shown by the retention of activity after treatment with
porcine liver esterase, hydrogen peroxide, basic methanol, or extremes in pH (e.g., pH 7 to 2 to 7 or pH 7 to 12 to 7). Additionally, C. albicans QSM is insensitive to trypsin, pronase, thermolysin, and
proteinase K (100 µg/ml for 2 h). Thus, QSM is unlikely to be a
conventional peptide. This distinction is important because of recent
evidence that the "asexual" C. albicans can, in fact, undergo mating (14, 23). It is also unlikely to be an HSL. The C. albicans QSM was tested versus three bacterial
strains which act as reporter strains for a wide range of bacterial
HSLs (5, 29). However, in no case did the C. albicans extracts elicit the indicated color development, while in
each case the appropriate bacterial positive controls did elicit that
response (data not shown).
Heat stability of QSM. The QSM activity of C. albicans was unchanged by heating at 100°C for 30 min or by autoclaving (data not shown), and activity was retained for at least 3 years at 4°C. It did not matter whether the supernatants were stored in glass or polypropylene vessels. Additionally, QSM activity remained unchanged following 12 freeze-thaw cycles (data not shown).
GC-MS.
Fractions enriched in the C. albicans QSM
showed peaks at 9.8, 9.9, and 10.0 min when examined by GC-MS. These
three peaks were analyzed with the MS system in both the chemical
ionization (CI) mode (Fig. 3), which
emphasizes the parent compound's molecular weight,
and the electron induced (EI) ionization mode (Fig.
4), which emphasizes fragmentation
data. The three peaks contained the
same parent ion (M+H) at m/z 223 in CI mode (Fig.
3) and exhibited the same fragmentation patterns in EI mode (Fig. 4).
Presumably, the three peaks represent isomers of one another. Analysis
of the results using a library search program (35)
suggested 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol (molecular
weight = 222.37), better known as the 15-carbon sesquiterpene farnesol. Farnesol can exist as both E and Z geometric isomers at both
the 2/3 and 6/7 double bonds, for a total of four possible isomers.
When a commercial sample of farnesol, containing a mixture of isomers,
was analyzed by GC-MS, three peaks were seen at 9.7, 9.85, and 10.0 min
(data not shown) with the relative peak areas of 6:57:37. The
commercial sample of (E,E)-farnesol showed only a single
peak at 10.0 to 10.1 min (data not shown). In both the CI and the EI
modes, the fragmentation patterns of QSM were identical to those of
commercial farnesol. At no stage of the QSM analysis did we observe
GC-MS peaks containing molecules of 154.2 or 290.5 molecular weight, as
would be expected for geraniol (C10) and geranylgeraniol
(C20), respectively.
|
|
Confirmation of farnesol by trimethylsilylation. Trimethylsilylation is a common method of derivatizing aliphatic alcohols for analysis by GC-MS. In CI mode, the peaks for derivatized mixed isomer farnesol shifted from 9.7, 9.85, and 10.0 min to 10.15, 10.22, and 10.35 min, respectively, while the parent ions shifted from 223 to 293 Da (data not shown). Trimethylsilyl derivatization of the C. albicans QSM also shifted the dominant peak from 10.0 to 10.35 min, and the new parent ion and fragmentation pattern were identical to those of the (E,E)-farnesol standard (data not shown). The addition of a single trimethylsilyl group is consistent with farnesol but inconsistent with two related C15 molecules: the hormone sirenin produced by the water mold Allomyces (11) and the farnesylated portion of the mating pheromones from Tremerogen A-10 and Tremerogen A-9291-I both of which have an extra hydroxyl on the 12 position of their farnesol modification (4).
Farnesol bioassay data. Commercial preparations of mixed-isomer farnesol (1-hydroxy-3,7,11-trimethyl-2,6,10-dodecatriene), (E,E)-farnesol, and mixed-isomer nerolidol (3-hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene) were tested for their ability to block GTF. All three showed strong QSM activity in that they reduced GTF by 50% at concentrations of 30 to 35 µM for the farnesol preparations and of ca. 60 µM for the nerolidol.
Two fractions (fractions 5 and 7) from a silica flash column separation of an ethyl acetate extract of the C. albicans supernate were compared by GC-MS. The three isomers of farnesol were separated by GC at 9.7, 9.85, and 10.0 min. For the comparatively inactive fraction 5 (87% GTF by bioassay), the three peaks were 65, 25, and 10% of the total peak area, respectively, whereas for the highly active fraction 7 (only 19% GTF by bioassay), the three peaks were 14, 6, and 80% of the total peak area, respectively.Confirmation of farnesol by TLC. The Rf values of commercial mixed isomer and (E,E)-farnesol were compared with those of the QSM-enriched fractions 5 and 7 from C. albicans supernatant. The mixed isomer farnesol ran as a broad band of Rf 0.45 to 0.47, while the (E,E)-farnesol ran as a single band with Rf 0.45, coeluting with the dominant band from the active fraction 7 from C. albicans. TLC analysis of the active chromatographic fractions derived from C. albicans also was conducted using p-anisaldehyde (data not shown). An advantage of this reagent is the ability to produce dramatically different colors depending upon the functionality present in the molecule (7). The two commercial farnesol bands stained blue green with p-anisaldehyde, as did the Rf 0.45 and 0.47 bands from C. albicans supernatant. All of the other bands from C. albicans stained pink or yellow with p-anisaldehyde (data not shown). The apparent shift in QSM's Rf value from 0.50 reported previously (6) to 0.45 merely reflects a switch in the TLC mobile phase from 25% ethyl acetate-hexane to 20% ethyl acetate-hexane.
Confirmation of farnesol by HPLC.
The commercial mixed isomer
and (E,E)-farnesol were compared with the QSM-enriched
fraction 7 from C. albicans by C18-reversed phase high-pressure liquid chromatography (HPLC) monitored at 210 nm
(Fig. 5). The mixed-isomer farnesol
showed peaks at 11.2, 11.7, and 12.4 min, which were present as the
percent area in the ratio 6:56:38. In a separate experiment the
(E,E)-farnesol showed a single peak at 12.4 min. This
separation of the farnesol isomers duplicates the separation achieved
by GC, and in both cases the (E,E)-isomer traveled the
furthest. Once again, just as with the GC comparison, the position of
the major peak for QSM enriched fraction 7 coincided with the peak for
(E,E)-farnesol (Fig. 5).
|
Farnesol and growth. In assessing the specificity of farnesol's QSM activity, it is important to determine whether farnesol slows down the overall growth rate for C. albicans. It did not. At concentrations of up to 250 µM, farnesol did not alter the growth rate for C. albicans at 30°C. Actively budding yeasts were observed in both cases.
| |
DISCUSSION |
|---|
|
|
|---|
Our studies demonstrate that there is an inoculum size effect in the dimorphic fungus C. albicans that is mediated by extracellular farnesol. Farnesol acts as a QSM in that it prevents the mycelial phase of growth, with a mycelium/yeast threshold at ca. 106 cells/ml in liquid culture. Both QSM purified from C. albicans and commercial farnesol shifted the morphology of C. albicans from mycelia to actively budding yeasts and, at concentrations of up to 250 µM, farnesol did not inhibit the growth rate of C. albicans. We hypothesize that the inoculum size effect is a common phenomenon in the biology of dimorphic fungi for which C. albicans is a useful model system.
We believe this report is the first structural identification of a quorum-sensing system in fungi and the first identification of farnesol production by C. albicans. Farnesol is not mentioned in Odds' (26) comprehensive review of Candida, two recent reviews of the lipids of C. albicans (16, 27), or two standard texts on fungal physiology (10, 12). Farnesol (QSM) is distinct from the morphogenic autoregulatory substance (MARS) isolated from C. albicans by Hazen and Cutler (13). Both QSM and MARS are extracellular molecules produced by C. albicans that act to suppress the yeast-to-mycelium transition. However, MARS differs in that it has a UV maximum at 270 nm, has a nitrogen-containing ring system, reacts with ninhydrin to form a yellow color, has to be bioassayed within 2 days, is inactivated by pH values of <4.5 or >9.0, and has no aroma.
The physical properties of farnesol are appropriate for its role as a
QSM; it is lipophilic, with a water solubility of only 1.2 mM
(17). In contrast, geranylgeraniol (C20) is
not suitable as a QSM because it is not soluble in water, while
geraniol (C10) is sufficiently soluble (7.6 mM) but is
generally toxic to strains of Candida (2). The
properties of farnesol as a QSM are consistent with those expected for
a fungal quorum-sensing system. (i) It is extracellular, is diffusible,
and can be removed from cells by washing. (ii) It is produced
continually during growth in amounts roughly proportional to cell mass.
(iii) It is produced by all six strains of C. albicans
tested. (iv) It blocks the induction of germ tubes by three chemically
distinct triggers: L-proline, GlcNAc, and serum. (v) Its
production is dependent on cell growth and not on a particular carbon
or nitrogen source. (vi) It alters cell morphology but does not alter
growth rate. Thus, its mode of action is likely more specific than just
a general inhibition of cell metabolism. (vii) It is produced at all
growth temperatures and is itself very heat stable. Even though QSM
functions by inhibiting the shift from yeasts to mycelia, C. albicans produces as much or more QSM at temperatures of
37°C,
where in vitro the cells are growing in the mycelial mode. This
continued production of QSM at temperatures of
37°C. (i) explains
why GTF assays at 37°C have to be conducted at cell densities of
107/ml; (ii) means that QSM formation should occur in the
human body during candidiasis; and (iii) precludes the simple,
discontinuous model wherein GTF and mycelial growth only occur at
temperatures of
37°C because QSM production does not occur at
temperatures above 35 to 36°C.
Farnesol has three carbon-carbon double bonds and exists in four
isomers. In this regard, we do not see any inconsistency between the
facts that C. albicans excretes primarily the
(E,E)-farnesol, while commercial (E,E)-farnesol
and mixed-isomer farnesol have equivalent activities and the closely
related sesquiterpene nerolidol is also highly active. The fungus
Helminthosporium sativum has an enzymatic system for the
cis-trans isomerization of the 2,3 double bond of farnesol
and epoxy-farnesol using nerolidol as an intermediate
(32). The presence of a similar system in C. albicans could allow interconversion of nerolidol and the two farnesols. Also, recognition that C. albican's QSM is
slightly volatile explains. (i) why measurements of QSM's heat
stability had to be conducted in sealed tubes; (ii) why there was a
gradual decline in QSM activity during stationary phase (Fig. 2), even though purified QSM was stable for at least 3 years at 4°C; and (iii)
the difficulty we experienced in making quantitative comparisons between QSM activity in the initial supernatants and the amounts of
farnesol purified following extraction into ethyl acetate
a high
proportion of the farnesol was lost when the ethyl acetate was reduced
in volume by rotary evaporation.
The older literature offers ample precedent for the existence of fungal
QSMs. Odds (26) cited 13 references that an
inoculum size of
106/ml favored filamentous growth. A
diffusible filament-suppressing molecule was hypothesized based on the
distinctive morphology of C. albicans on agar plates
following parallel streaking (24) or multiple
cross-streaking (25). For instance, Nickerson and Chung
(25) noted the "suppression of filamentation in strain 582 (a wild-type dimorphic strain of C. albicans) along the
length of the streak facing strain 806 and the appearance of filaments in 582 only at the free ends of lateral streaks," while with three parallel streaks filamentous cells only arose from the outer borders of
the two outer streaks (24). Similarly, Shepherd and
Sullivan (30) noted that some C. albicans
strains needed to be "activated or conditioned" for GTF by a
prolonged aeration under nongrowing conditions. This conditioning, like
the successive cell washings described here, would serve to remove
excess QSM from the C. albicans cells.
Recognition that farnesol acts to suppress mycelial development in C. albicans in a quorum-sensing manner suggests that farnesol might be the first of a novel class of antifungal compounds. C. albicans normally occurs as a yeast in the human gastrointestinal tract but can form germ tubes in response to an unknown chemical inducer(s). The germ tubes (mycelia) can invade the intestinal wall to enter the blood stream. This morphological transformation from yeast to mycelia is a crucial step in the pathogenesis of C. albicans. Blocking this transition could block the pathogenic nature of this opportunist. These compounds would neither kill the fungi nor prevent their growth. Instead, they would limit their growth to a single morphological form and in so doing restrict pathogenesis. Nonfilamentous mutants of C. albicans are often avirulent (22). We believe this type of single morphology therapy could be especially useful in immunocompromised patients because it would not upset the natural resident flora. Additionally, because it does not kill the fungus, selection for farnesol-tolerant mutants should not be as intense.
Finally, we suggest that the effects of excreted farnesol may be different in vitro and in vivo. All of our results so far have been in vitro; accumulated farnesol (10 to 50 µM) shifted the morphology to budding yeasts. If this suppression of mycelial development also occurs in vivo, the effect of exogenous farnesol should be protective because nonfilamentous mutants of C. albicans are often avirulent (22). However, in vivo farnesol excretion may instead act as a virulence factor. In patients, C. albicans accumulates to very high cell densities and then some of these cells penetrate the tissue. Growth to high cell densities in the restricted microenvironments of the host mucosal foci may produce enough farnesol so that the cells lining the microabscesses no longer constitute an effective barrier to fungal penetration. Free farnesol is not normally present at detectable levels in human plasma (28). The lipophilic properties of free farnesol would favor its membrane localization, and thus it could alter the membrane fluidity of the host cells. Alternatively, according to Voziyan et al. (34), the farnesol could reduce diacylglycerol production. Since diacylglycerol is an activator for protein kinase C, farnesol could inhibit cell growth, leading to apoptosis (34), and thus create an entry site for invading C. albicans. Tests with farnesol and C. albicans in a mouse model system (9) should resolve these competing hypotheses.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Bill Gerwick, Department of Pharmacy, Oregon State University, for hospitality during K.W.N's recent sabbatical, as well as for the use of GC-MS equipment with a computerized database, Gloria Zeller (Oregon State University) for technical assistance with the bacterial HSL indicator strains, Antonio Romano for pointing out how the early work of W. J. Nickerson indicated a diffusible filament-suppressing molecule, and Sondra Atkins for assistance with manuscript preparation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: School of Biological Sciences, University of Nebraska, Lincoln, NE 68588-0666. Phone: (402) 472-2253. Fax: (402) 472-8722. E-mail: knickerson1{at}unl.edu.
Present address: Cell Biology Department, Vanderbilt University,
Nashville, Tenn.
Present address: University of Nebraska Medical Center, Omaha, Nebr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Atlas, R. M. 1993. Handbook of microbiological media. CRC Press, Boca Raton, Fla. |
| 2. | Bard, M., M. R. Albrecht, N. Gupta, C. J. Guynn, and W. Stilwell. 1988. Geraniol interferes with membrane functions in strains of Candida and Saccharomyces. Lipids 23:534-538[Medline]. |
| 3. | Brown, A. J. P., and N. A. R. Gow. 1999. Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol. 7:333-338[CrossRef][Medline]. |
| 4. |
Caldwell, G. A.,
F. Naider, and J. M. Becker.
1995.
Fungal lipopeptide mating pheromones: a model system for the study of protein prenylation.
Microbiol. Rev.
59:406-422 |
| 5. | Cha, C., P. Gao, Y.-C. Chen, P. D. Shaw, and S. K. Farrand. 1998. Production of acyl-homoserine lactone quorum sensing signals by gram-negative plant-associated bacteria. Mol. Plant-Microbe Interact. 11:1119-1129[Medline]. |
| 6. | Cho, S. C., P. H. Dussault, A. D. Lisec, E. C. Jensen, and K. W. Nickerson. 1999. Metathesis-based synthesis of jasmonate and homojasmonate lactones, candidates for extracellular quorum sensing molecules in Candida albicans. J. Chem. Soc. Perkin Trans. 1:193-196. |
| 7. | Coscia, C. J. 1984. Handbook of chromatography: terpenoids. CRC Press, Boca Raton, Fla. |
| 8. |
Dabrowa, N.,
S. S. S. Taxer, and D. H. Howard.
1976.
Germination of Candida albicans induced by proline.
Infect. Immun.
13:830-835 |
| 9. |
de Repentigny, L.,
M. Phaneuf, and L.-G. Mathieu.
1992.
Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact immunocompromised mice.
Infect. Immun.
60:4907-4914 |
| 10. | Garraway, M. O., and R. C. Evans. 1984. Fungal nutrition and physiology John Wiley & Sons, New York, N. Y. |
| 11. | Gooday, G. W., and D. J. Adams. 1993. Sex hormones and fungi. Adv. Microb. Physiol. 34:69-145[Medline]. |
| 12. | Griffin, D. H. 1994. Fungal physiology, 2nd ed. Wiley-Liss, New York, N. Y. |
| 13. |
Hazen, K. C., and J. E. Cutler.
1983.
Isolation and purification of morphogenic autoregulatory substance produced by Candida albicans.
J. Biochem.
94:777-783 |
| 14. |
Hull, C. M.,
R. M. Raisner, and A. D. Johnson.
2000.
Evidence for mating of the "asexual" yeast Candida albicans in a mammalian host.
Science
289:307-310 |
| 15. | Joshi, K. R., D. A. Bremner, J. B. Gavin, P. B. Herdson, and D. N. Parr. 1973. The formation of germ tubes by Candida albicans in sheep serum and trypticase soya broth. Am. J. Clin. Pathol. 60:839-842[Medline]. |
| 16. | Kitajima, Y., and Y. Nozawa. 1996. Lipids and dimorphism of Candida albicans and Sporothrix schenckii, p. 219-233. In R. Prasad, and M. A. Ghannoum (ed.), Lipids of pathogenic fungi. CRC Press, Boca Raton, Fla. |
| 17. | Knobloch, K., A. Pauli, B. Iberl, N. Weis, and H. Weigand. 1988. Mode of action of essential oil components on whole cells of bacteria and fungi in plate tests, p. 287-299. In P. Schreier (ed.), Bioflavour'87. Walter de Gruyter, Berlin, Germany. |
| 18. |
Kügler, S.,
T. S. Sebghati,
L. G. Eissenberg, and W. E. Goldman.
2000.
Phenotypic variation and intracellular parasitism by Histoplasma capsulatum.
Proc. Natl. Acad. Sci. USA
97:8794-8798 |
| 19. | Kulkarni, R. K., and K. W. Nickerson. 1981. Nutritional control of dimorphism in Ceratocystis ulmi. Exp. Mycol. 5:148-154. |
| 20. | Lee, K. L., H. R. Buckley, and C. C. Campbell. 1975. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 13:148-153[Medline]. |
| 21. | Lisec, A. D. 1998. Quorum sensing in Candida albicans: partial purification of two extracellular candidate molecules. M.S. thesis. University of Nebraska, Lincoln. |
| 22. | Lo, H. J., J. R. Köhler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949[CrossRef][Medline]. |
| 23. |
Magee, B. B., and P. T. Magee.
2000.
Induction of mating in Candida albicans by construction of MTLa and MTL strains.
Science
289:310-313 |
| 24. |
Nickerson, W. J.
1954.
An enzymatic locus participating in cellular division of a yeast.
J. Gen. Physiol.
37:483-494 |
| 25. | Nickerson, W. J., and C. W. Chung. 1954. Genetic block in the cellular division mechanism of a morphological mutant of a yeast. Am. J. Bot. 41:114-120[CrossRef]. |
| 26. | Odds, F. C. 1988. Candida and candidosis, 2nd ed. Bailliere Tindall, London, England. |
| 27. | Prasad, R., A. Koul, P. K. Mukherjee, and M. A. Ghannoum. 1996. Lipids of Candida albicans, p. 105-137. In R. Prasad, and M. A. Ghannoum (ed.), Lipids of pathogenic fungi. CRC Press, Boca Raton, Fla. |
| 28. | Saisho, Y., A. Morimoto, and T. Umeda. 1997. Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. Anal. Biochem. 252:89-95[CrossRef][Medline]. |
| 29. |
Shaw, P. D.,
G. Ping,
S. L. Daly,
C. Cha,
J. E. Cronan, Jr.,
K. L. Rinehart, and S. K. Farrand.
1997.
Detecting and characterizing N-acyl-homoserine lactone signal molecules by thin-layer chromatography.
Proc. Natl. Acad. Sci. USA
94:6036-6041 |
| 30. | Shepherd, M. G., and P. A. Sullivan. 1983. Candida albicans germ-tube formation with immobilized GlcNAc. FEMS Microbiol. Lett. 17:167-170[CrossRef]. |
| 31. | Simonetti, N., V. Strippoli, and A. Cassone. 1974. Yeast-mycelial conversion induced by N-acetyl-D-glucosamine in Candida albicans. Nature 250:344-346[CrossRef][Medline]. |
| 32. | Suzuki, Y., and S. Marumo. 1972. Trans to cis-2,3 double bond isomerization of epoxyfarnesol and farnesol by fungus. Tetrahedron Lett. 50:5101-5104[CrossRef]. |
| 33. |
Tempé, J.,
A. Petit,
M. Holsters,
M. van Montagu, and J. Schell.
1977.
Thermosensitive step associated with transfer of the Ti plasmid during conjugation: possible relation to transformation in crown gall.
Proc. Natl. Acad. Sci. USA
74:2848-2849 |
| 34. | Voziyan, P. A., J. S. Haug, and G. Melnykovych. 1995. Mechanism of farnesol cytotoxicity: further evidence for the role of PKC-dependent signal transduction in farnesol-induced apoptotic cell death. Biochem. Biophys. Res. Commun. 212:479-486[CrossRef][Medline]. |
| 35. | Wise, M. L., J. Rossi, and W. H. Gerwick. 1997. Characterization of the substrate binding site of polyenoic fatty acid isomerase, a novel enzyme from the marine alga Ptilota filicina. Biochemistry 36:2985-2992[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»